Overview
Epitalon (also spelled Epithalon or Epithalone) is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly, developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology in Russia. It is the synthetic version of epithalamin, a polypeptide extract from the bovine pineal gland that showed remarkable life-extending properties in early Russian gerontology research spanning the 1980s and 1990s.
The primary mechanism attributed to Epitalon is the activation of telomerase, the enzyme responsible for maintaining telomere length at chromosome ends. Telomere shortening is one of the hallmarks of cellular aging, and compounds that can activate telomerase have been of intense interest in longevity research. Epitalon has been shown to activate telomerase in human somatic cells in vitro and to extend telomere length in fibroblast cultures.
Beyond telomerase activation, Epitalon is studied for its effects on the pineal gland, where it appears to regulate melatonin production and restore circadian rhythm function that typically degrades with age. This neuroendocrine regulatory role connects Epitalon to broader theories of aging that implicate pineal gland decline as a driver of age-related physiological deterioration.
While Epitalon has accumulated an unusually large body of research for a bioregulatory peptide—including animal lifespan studies showing 12–24% life extension—most research has been conducted in Russian institutions, and the peptide has not undergone the rigorous double-blind, placebo-controlled trials expected by Western regulatory agencies.
Quick facts
- Mechanism
- Tetrapeptide activating telomerase and regulating pineal function
- Primary use
- Anti-Aging & Telomere Maintenance
- Evidence
- limited
- FDA
- Not approved
- Route
- Subcutaneous injection or intranasal
- Typical results
- Telomerase activation observed in cell cultures; anti-aging effects in long-term animal studies
Chemical information
Epitalon (C₁₄H₂₂N₄O₉) is a bioregulator compound with a molecular weight of 390.35 g/mol. Its structural characteristics underpin its biological activity in bioregulation and peptide signaling.
How Epitalon works
Epitalon's primary documented mechanism is the direct activation of telomerase reverse transcriptase (hTERT), the catalytic subunit of telomerase. In vitro studies have demonstrated that Epitalon treatment increases hTERT gene expression and telomerase activity in human pulmonary fibroblasts, retinal pigment epithelial cells, and other somatic cell types. By maintaining telomere length, Epitalon may delay the onset of replicative senescence—the point at which cells cease dividing due to critically short telomeres.
Epitalon's interaction with the pineal gland appears to involve restoration of melatonin biosynthetic enzyme activity, particularly arylalkylamine N-acetyltransferase (AANAT) and hydroxyindole-O-methyltransferase (HIOMT). With aging, pineal gland calcification and functional decline lead to reduced melatonin production, disrupted circadian rhythms, and loss of melatonin's powerful antioxidant protection. Epitalon may reverse these age-related changes.
The peptide also demonstrates antioxidant properties, both directly through melatonin upregulation and indirectly through enhanced expression of antioxidant enzymes. In aging rodent models, Epitalon treatment reduced lipid peroxidation, increased superoxide dismutase activity, and improved overall oxidative stress markers across multiple organ systems.
Animal longevity studies conducted by Khavinson's group have shown that Epitalon treatment beginning in middle age can extend maximum lifespan by 12–24% in rodents, with concurrent improvements in immune function, tumor resistance, and organ-specific biomarkers. These are among the most robust life-extension results achieved with a peptide compound, though they require independent replication.
- Telomerase activation: Directly increases hTERT expression and telomerase activity in somatic cells
- Telomere elongation: Extends telomere length in fibroblasts beyond the normal Hayflick limit
- Pineal gland regulation: Restores melatonin biosynthetic enzyme activity in aged pineal tissue
- Circadian rhythm normalization: Helps restore age-degraded sleep-wake cycle regulation
- Antioxidant enhancement: Increases SOD activity and reduces lipid peroxidation markers
- Immune function restoration: Improves T-cell function and thymic output in aged animals
Pharmacokinetics
| Parameter | Value | Significance |
|---|---|---|
| Molecular weight | 390.35 g/mol | Small tetrapeptide with good tissue penetration |
| Half-life | ~2–3 hours (estimated) | Short half-life; typical protocols use daily or cycling administration |
| Route | Subcutaneous injection | Most common research administration route |
| Telomerase effect onset | 24–48 hours in vitro | Rapid gene expression changes in cell culture |
| Melatonin response | 1–2 weeks | Pineal effects develop over days to weeks |
Dosing & administration
Epitalon dosing varies by indication and individual factors. No FDA-approved dosing exists for this compound; protocols in the literature derive from limited clinical or preclinical data and practitioner experience.
Any use should be conducted under qualified medical supervision with appropriate monitoring of safety markers.
Important: These dosing ranges are not FDA-approved. Any use should be under qualified medical supervision.
Side effects & safety
Safety data for Epitalon is primarily derived from preclinical studies and limited human data. Long-term effects in humans remain incompletely characterized.
Common
- • Injection site reactions (redness, swelling)
- • Mild headache
- • Temporary fatigue
- • Nausea (dose-dependent)
- • Flushing
Serious / potential risks
- • Allergic reactions (rare)
- • Hormonal disruption with prolonged unsupervised use
- • Potential drug interactions
- • Unknown long-term effects in humans
Drug interactions
| Medication | Interaction | Recommendation |
|---|---|---|
| Melatonin supplements | Epitalon stimulates endogenous melatonin; additive effects possible | May reduce need for exogenous melatonin; monitor sleep quality |
| Immunosuppressants | Epitalon enhances immune function, potentially opposing immunosuppression | Avoid in transplant recipients or autoimmune conditions on immunosuppression |
| Anti-cancer therapies | Telomerase activation is a concern in cancer biology | Contraindicated in active cancer; discuss with oncologist |
| Pineal-affecting drugs | Compounds affecting melatonin pathways may interact | Monitor for excessive sedation or circadian disruption |
Storage & handling
Lyophilized (powder)
- • Store at -20°C to 4°C (freezer or refrigerator)
- • Protect from light and moisture
- • Stable for 12–24 months when stored properly
- • Keep in original sealed container until reconstitution
Reconstituted solution
- • Refrigerate at 2–8°C after reconstitution
- • Use bacteriostatic water for multi-dose reconstitution
- • Typical stability: 14–28 days refrigerated
- • Do not freeze reconstituted solution
Cost & availability
| Source | Cost | Notes |
|---|---|---|
| Research suppliers | Varies widely | Quality and purity vary significantly between sources |
| Compounding pharmacies | Prescription required | Higher quality assurance and purity testing |
The bottom line
Epitalon is a bioregulator compound with research interest in telomerase, anti-aging, pineal gland, longevity. While preclinical evidence is encouraging, it remains investigational and is not FDA-approved. Any use should be under qualified medical supervision.
Best for
- • Researchers studying bioregulation and peptide signaling
- • Individuals interested in telomerase under medical guidance
Not for
- • Self-administration without medical supervision
- • Pregnant or breastfeeding individuals
- • Individuals with contraindicated conditions
Related compounds
FOXO4-DRI
Senolytic peptide targeting cellular aging through a different mechanism
Humanin
Mitochondrial-derived peptide with cytoprotective anti-aging properties
SS-31
Mitochondria-targeted peptide for cellular energy and longevity
Pinealon
Related Khavinson peptide targeting pineal gland and brain function
Frequently asked questions
References
- [1] Khavinson VK, Bondarev IE, Butyugov AA.. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med (2003). doi: 10.1023/A:1026195601230 PMID: 14631594
- [2] Anisimov VN, Khavinson VK.. Peptide bioregulation of aging: results and prospects. Biogerontology (2010). doi: 10.1007/s10522-009-9249-8 PMID: 19830585
- [3] Khavinson V, Diomede F, Mironova E, et al.. AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis. Molecules (2020). doi: 10.3390/molecules25224885 PMID: 33105659
- [4] Anisimov VN, Khavinson VKh, Provinciali M, et al.. Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Int J Cancer (2002). doi: 10.1002/ijc.10266 PMID: 12210729
- [5] Khavinson VK.. Peptides and Ageing. Neuroendocrinol Lett (2002). PMID: 12163944